Sera from 26 rats bearing tumours induced by wildtype (wt) and mutant human adenovirus type 12 (Ad 12), or by cells transformed with these viruses, were analysed for antibodies against the early region 1 (El) transforming proteins. Six Adl2-fl-galactosidase fusion proteins encoding different regions of the Ad 12 E 1 proteins were constructed. The sera from the tumourbearing animals reacted most strongly with the fusion protein encoding the N terminus of the E1A protein.
Sera from 26 rats bearing tumours induced by wildtype (wt) and mutant human adenovirus type 12 (Ad 12), or by cells transformed with these viruses, were analysed for antibodies against the early region 1 (El) transforming proteins. Six Adl2-fl-galactosidase fusion proteins encoding different regions of the Ad 12 E 1 proteins were constructed. The sera from the tumourbearing animals reacted most strongly with the fusion protein encoding the N terminus of the E1A protein.
Tumour-bearing rats exposed to the E1B 54K and 19K proteins showed strong reactions with the N terminus of the 54K protein and the C terminus of the 19K protein. Monospecific polyclonal antisera were raised against five of the fusion proteins by immunization of rats and rabbits; these sera cross-reacted with the purified native protein. No antibodies could be obtained which recognized a fusion protein containing amino acids 136 to 268 of the 54K protein. The fusion proteins were also used to purify monospecific antisera from tumour-bearer sera using affinity chromatography.
Human adenovirus type 12 (Adl2) is an oncogenic virus which contains genes whose products malignantly transform a wide variety of mammalian cells, including those of rats (Yano et al., 1977) and humans (Byrd et al., 1982) . Using DNA transfection and genetic analysis, the genes responsible for malignant transformation have been shown to reside in the region first expressed after infection, early region 1 (El) (van der Eb et al., 1977; Gallimore et al., 1974) which has been subdivided into EIA and E1B (Berk & Sharp, 1978) . The E1A region [0 to 4-5 map units (m.u.)] encodes two major transcripts (13S and 12S mRNAs) which are coterminal at both the 3' and 5' ends but differ in the extent of internal splicing (Berk & Sharp, 1978) ; the products of these mRNAs have an Mr of approximately 41K as determined by SDS-PAGE (Jochemsen et al., 1980) . Since the proteins are encoded by the same reading frame, their amino acid sequences are identical, with the exception of an additional internal peptide in the protein encoded by the 13S mRNA; the 13S and 12S transcripts encode proteins of 266 and 235 amino acids respectively. Morphological transformation of cells can be accomplished by transfection with E 1A alone but the E 1B region (4.5 to 11.2 m.u.), in some as yet unidentified way, enhances both transformation frequency and malignant potential (van der Eb et al., 1979; Gallimore et al., 1985) . E1B encodes two major polypeptides (Bos et al., 1981) which are transcribed from overlapping genes but have no shared amino acid sequence because they are encoded in different reading frames. These two major products are transcribed from the E 1B region early in infection and are translated from a 22S mRNA. The smaller E1B protein is 163 amino acids in length and has an Mr of 19K; the larger E1B protein is 482 amino acids in length and has an Mr of 54K. The generation of antibodies for the detection and study of Ad transforming proteins has previously been accomplished by the use of synthetic peptides (Lucher et al., 1984) , bacterially expressed proteins (Scott et al., 1984; Schugart et al., 1987) , or by the use of tumourbearer serum (TBS) (Rowe et al., 1983) . Relatively few studies have been carried out to define the degree or quality of humoral responses to individual E 1 proteins in tumour-bearing animals. The aim of this study was to examine the Adl2 anti-E1 antibodies present in tumourbearing rats, to identify the regions of those proteins which were recognized and, for the first time, to compare the response of individual hosts to different regions of these proteins.
Six fragments of the Adl2 genome encoding parts of the Adl2 E1 proteins were excised from Adl2 vectors using appropriate restriction endonucleases and cloned into the SmaI site of pEX vector 1, 2 or 3 to construct six Adl2-pEX fusions, E1A-N, 19M, 19C, 54N, 54M and 54C. The vectors encoded different regions of the three Graphical representation of Western blot analysis to show the reaction of each TBS with the six fusion proteins and the 41K and 54K native proteins. The graphs represent the following proteins: Fig. 1 (a). The Adl 2-pEX constructs were transformed into Escherichia coli strain pop 2136 and sequenced across the pEX-Adl 2 junction; they were found to be correctly inserted and in frame. Large-scale preparation and purification of the fusion proteins was carried out according to the method of Doorbar et al. (1986) .
The fusion proteins were used to determine whether rat TBS was able to react with the various regions of the E 1-encoded proteins. Tumours were produced in Hooded Lister rats by a single intraperitoneal injection of 2 × 106 Ad 12-transformed baby rat kidney cells (expressing all or some of the E1A, 19K and 54K proteins) into adult rats, or 2 × 108 p.f.u, wild-type Adl2 (or higher for mutant viruses) into newborn rats, as shown in Table 1 . Using Western blotting, 27 sera (including serum 20, a preimmune serum) were tested for reactivity with the fusion proteins; some were tested also for reactivity with E 1A and 54K proteins partially purified from rat tumour material (Grand & Gallimore, 1984) . The fusion proteins (2 p.g per lane) were resolved on 10~ SDS-polyacrylamide gels. TBS was used at a dilution of 1:400 in PBS, 5~ dried milk, 0-1 ~ Tween 20 and detected using antirat IgG-horseradish peroxidase conjugate at 1:1000 (Sigma). The blots for each serum were quantified by scanning photographic negatives using an LKB Ultra Scan Laser Densitometer. Using this method the area sum of each peak minus the area sum of any peak detected with pEX protein alone was a direct representation of the reaction of each TBS with each fusion protein. Fig. 1 (b) shows the results. By comparing the intensity of the response for individual sera the general order of reactivity with the fusion proteins was established to be E1A > 54N and 19C > 19M > 54C; there was virtually no reaction of any serum with 54M. Sera 24 and 26, derived from rats bearing tumours induced by viruses encoding 54K and E1A mutant proteins (Table 1) respectively, showed a greater response to 19C than E1A-N. It will be necessary to examine many more TBSs of this type before concluding whether the increased response to 19C was due to the viral mutations. Animals bearing tumours induced by cells transformed with the AccI H DNA fragment (sera 21 and 22) (see Table 1 ) have only ever been exposed to E1A and possibly the N terminus of the 19K protein. Therefore it would not be expected that these sera react with fusion proteins other than E1A-N. However, serum 22 reacted weakly with a protein that had the appropriate Mr to be the 54N fusion protein (although it does not recognize the native protein). This result cannot be explained at present. Sera 14 to 22 would not be expected to and did not react with 54M and 54C, as these were induced by cell lines which do not encode these regions of Adl 2. Sera 23 to 25 were from animals bearing tumours induced by a 54K gene deletion mutant (del 620) which does not encode amino acids 96 to 326 of the 54K protein. The observed reactivity of these sera with the 54N fusion protein suggests that a major epitope is encoded between amino acids 21 and 96. Serum 23 reacted weakly with 54M but this, like most of the positive reactions seen with 54M fusion protein, was due to a fine band of protein of greater Mr than the main fusion protein band and was therefore considered to be artefactual.
In terms of the E1B 54K protein, cells transformed with the HindIII G DNA fragment contain only the DNA encoding the N terminus of this protein. The results obtained indicate that the N terminus is translated into a truncated 54K protein because sera 14 to 19 clearly recognized the fusion protein ( Fig. 1 b panel ii) and also the whole protein ( Fig. 1 b panel viii) . Of those sera tested against the E1A and 54K proteins ( Fig. 1 b panels vii and viii), some sera which recognized the fusion proteins did not recognize the intact proteins. This may be due to the extreme denaturing conditions used in the protein preparation (Grand & Gallimore, 1984) which may have destroyed epitopes which are still retained by the fusion proteins even after SDS-PAGE.
The sera were also tested by ELISA and these results were very similar to those obtained by Western blotting. Each ELISA was carried out on a different plate for each fusion protein so the results were comparable between sera but not between proteins. By ELISA almost all the sera reacted strongly with E1A-N and, for those with the potential to react with the 54K protein, also with 54N. Additionally, the majority of TBSs which had been exposed to the 54K protein C terminus showed a positive reaction with 54C; however, only 50~ of the sera exposed to the entire 19K protein reacted with 19M, although nearly all recognized 19C. These results were consistent in three separate experiments. It is likely, therefore, that the differing results obtained with Western blotting and ELISA for 19M and 54C may illustrate that the proteins bind differently to the solid phase in these methods, perhaps preventing epitopes from being made available to the antibodies.
The lack of reaction to 54M as assayed by both methods could be explained by one of the following alternatives: firstly, this region may not be immunogenic; secondly, the epitopes present may have been denatured by the SDS; thirdly, the fl-galactosidase protein may be masking the epitopes or affecting the conformation of the protein in such a way that they are hidden. This fusion protein runs at approximately 10K less than the Mf expected on SDS-PAGE gels, suggesting a truncated molecule. However use of a second primer enabled the entire Adl2 E1B insert to be sequenced and showed it to be intact with no anomalies (data not shown). The fusion proteins were also used to raise polyclonal antisera in rats and outbred New Zealand White rabbits. Antibodies raised against SDS-denatured fusion proteins were shown to recognize the native viral protein. The E 1A-N sera were tested for their ability to immunoprecipitate the E1A protein from [3SS]methionine-labelled Adl2-infected human embryo retinoblast (HER) cells transformed with Adl2 E1 (Byrd et al., 1982) , using the protocol described by Paraskeva et al. (1982) . Fig. 2(a) shows an autoradiograph of a urea gel on which the immunoprecipitates were electrophoresed. The resulting two bands are characteristic of the protein products of the 12S and 13S E1A mRNA transcripts (Grand & Gallimore, 1984) . Both rat and rabbit polyclonal fusion protein antisera precipitated E1A polypeptides from the infected cells as shown in lanes 1 and 2 respectively. The three TBSs (lanes 3, 4 and 5) were also able to immunoprecipitate E1A from the infected cells and, more weakly, from the transformed cells (lanes 8, 9 and 10). This illustrates that when used at the same dilution (10 ~tl serum per 12.5 x 105 cells in 100 ktl), the TBS has either a higher concentration of specific antibody or the antibodies are of a higher affinity and/or avidity than polyclonal antisera. No reactivity was seen with any of the preimmune sera (results not shown).
Immunoprecipitations of [3SS]methionine-labelled Adl2-infected human embryo kidney cells with fusion protein antisera showed that the 19K protein was clearly recognized by antisera to both the 19C and 19M fusion proteins (see Fig. 2b ). (The high Mr protein precipitated is probably the Adl2 hexon and it appears that the polyclonal antibodies show some non-specific crossreactivity with it.) By Western blotting, it was also demonstrated that both the 54N and 54C fusion protein antisera detected semi-purified intact 54K protein. Fig. 2(c) is an autoradiograph of a Western blot which shows that the TBSs, and the 54N and 54C antisera detect two clear bands of protein, the monomeric form of the larger E1B protein at 54K and also its 108K dimer. The results obtained were the same for the sera of all three rats tested in each group. The laser scan results indicated that the TBSs showed little reactivity with the 54C fusion protein; however, the 54C polyclonal antisera were able to recognize the intact protein by the same method, indicating that this region is immunogenic. The TBSs were able to detect the 54C fusion protein by ELISA, suggesting that the epitope on the fusion protein is somehow hidden during Western blotting, possibly by binding to the nitrocellulose. The 54M and preimmune sera did not detect either the monomer or the dimer.
Previous work to determine whether polyclonal antisera could be raised to Adl2 54K-fl-galactosidase fusion proteins (Schugart et al., 1987) showed that only very weak antibodies could be raised against the protein containing amino acids 158 to 205 (present in the 54M fusion protein described in this paper). However, strong antibodies were raised against a protein containing amino acids 64 to 205 of the 54K protein, the first 93 amino acids of which overlap with the 54N fusion protein documented in this paper. The results with the del 620 sera (sera 23 to 25) indicate the likelihood of a major B cell epitope within amino acids 21 to 95 (base pairs 1904 to 2129) of the 54K protein. Taken together it may be that the antisera discussed in this paper and those obtained by Schugart et al. (1987) recognize a common epitope between amino acids 64 and 95 of the 54K protein. Further work would be needed to confirm this. In an earlier paper Schugart et al. (1985) showed that an octapeptide (encoded by the 54C fusion gene described in this paper) was immunogenic, again agreeing with the results obtained here.
Additional studies using the fusion proteins were carried out to determine when the antibodies against the E1 proteins were produced during tumour development. Rats were injected with 2 x 106 cells transformed with the Adl2 EcoRI C DNA fragment to produce tumours within approximately 8 weeks. Test bleeds were taken at weekly intervals and tested by ELISA against the fusion proteins for the presence of antibodies to the Adl2 E1A, 19K and 54K proteins. No response was observed at 14 days post-injection (p.i.) but by 21 days p.i. antibodies to all three E1 proteins could be detected. The implication of this is that a humoral response is mounted to all the E 1 proteins simultaneously, regardless of whether the antigen is an internal or membrane-bound protein (Grand & Gallimore, 1984; Smith et al., 1989) . This suggests that either cell autolysis occurs early during tumour development or that tumour-specific antigen becomes accessible to the immune system without ceil death.
Having conclusively demonstrated that the TBS could recognize the fusion proteins, monospecific antibodies were purified from these sera by affinity chromatography. E1A-N, 19C, 19M and 54N fusion proteins were bound to CNBr-activated Sepharose 4B-CI and used to isolate antibodies specific for the appropriate Adl2 E1 polypeptide. Of course, antibodies which recognized determinants only present in native protein were not purified by this procedure. Future investigations, based on the use of immunoprecipitation, will be undertaken to elucidate this point.
A number of different approaches have been utilized to examine host-virus interactions during Ad tumorigenesis (Raska et al., 1980; Kast et al., 1989; Gallimore & Williams, 1982; Raska & Gallimore, 1982) . This study initiated an examination of humoral responses to specific regions of those Adl2 proteins previously shown to be required for malignant transformation. It is now known that B cell epitopes are usually discontinuous and that antigenicity of these epitopes is totally dependent upon the conformation of these polypeptides (Padlan et al., 1989) . The results of this study were obtained using SDSdenatured proteins and therefore do not account for determinants which are destroyed by SDS. However antisera raised against the SDS-denatured fusion proteins were able to recognize the native protein. Also, the TBSs raised against the native protein were able to recognize the SDS-denatured fusion proteins by immunoprecipitation. Therefore we suggest that these denatured fusion proteins are able to express enough of the discontinuous epitopes in a conformation such that the antibodies with high enough affinity and/or avidity bind. It may even be that those epitopes more resistant to SDS denaturation are more important to the immune system than those which are easily denatured.
This study is the first of its kind to compare the in vivo B cell response to the Adl2 E1 proteins. The major conclusion to be drawn is that, of the regions studied, the greatest humoral response is directed towards the E1A protein. The N terminus of the 54K protein and the C terminus of the 19K proteins also elicit strong antibody responses with weaker responses to the C terminus of the 54K and the middle region of the 19K proteins; little or no response is directed towards the middle region of the 54K protein. The E1A-N fusion protein examined here represents the first 135 amino acids of both the 12S and 13S EIA-encoded polypeptides, which includes conserved regions 1 and 2 (Moran & Mathews, 1987) . Previous studies have shown that antibodies can be produced to an Ad2 E1A fusion protein which maps to amino acids 32 to 120 (Tsukamoto et al., 1986) and also to an Adl2 E1A fusion protein encoding the N-terminal Short communication 131 amino acids of Adl2 E1A (Scott et al., 1984) . Our finding that TBSs show a highly significant humoral response directed towards amino acids 1 to 135 of E1A and also to amino acids 21 to 95 of 54N, suggests that major B cell epitopes lie within these regions. By employing an approach similar to that of Doorbar et al. (1988) , it may be possible to map these epitopes in more detail using monoclonal antibodies. The ability of antisera against the fusion proteins to detect the native protein and the success in using the fusion proteins to purify antibodies specific for these regions from TBS has enabled the generation of a panel of monospecific antisera. These will now be used to determine whether the N and C termini of the E 1 proteins perform functions independent of one another and whether these antibodies have any function in antibody-dependent cellmediated immunity directed against tumours.
